Intellectual property

WO/2017/09005. Single-chain fusion constructs comprising multimeric antibody fragments fused to collagen trimerization domains.
Includes mono- and multi-specific multivalent single-chain polypeptide molecules and derivatives, preferably multispecific single-chain (tandem) Trimerbodies with defined stoichiometry, to nucleic acid sequences, encoding vectors, and host cells expressing the same. It further relates to methods of production, pharmaceutical compositions, kits, methods of treatment, use as diagnostics or imaging reagents, and combination therapies.
 
 
WO/2012/049328. Generation of multifunctional and multivalent polypeptide complexes with collagen XVIII trimerization domain. 
Comprises mono- and multi-specific multivalent trimeric antibodies with defined stoichiometry, nucleic acid sequences, vectors, host cells, methods of production, pharmaceutical compositions, kits, methods of treatment, use as diagnostics, imaging and combination therapies.

Latest News

LeadArtis to present at the final Chemostart pitching initiative in recognition of its highly innovative R&D activity
31-01-2019
The Chemostart initiative (sponsored by the Chemo company) launched in 2018 as a call for...
LeadArtis project finalist of the Kaertor and J&J innovation award in recognition of its highly innovative R&D activity
08-11-2018
The Kærtor Foundation together with Janssen (a Johnson & Johnson company) launched in 2018...
Leadartis discloses the project: ATTACK-Cancer immunotherapy by bispecific antibodies that recruit T lymphocytes
11-12-2018

LeadArtis is pleased to announce its participation as coordinator of the ATTACK project (Cancer...